First Trust Direct Indexing L.P. raised its position in shares of Haleon plc (NYSE:HLN – Free Report) by 22.1% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 15,316 shares of the company’s stock after purchasing an additional 2,773 shares during the quarter. First Trust Direct Indexing L.P.’s holdings in Haleon were worth $128,000 at the end of the most recent quarter.
Other hedge funds also recently modified their holdings of the company. City State Bank acquired a new position in Haleon during the first quarter valued at $25,000. American National Bank purchased a new stake in shares of Haleon in the second quarter worth approximately $25,000. CoreFirst Bank & Trust acquired a new stake in shares of Haleon during the fourth quarter worth approximately $26,000. Ahrens Investment Partners LLC purchased a new position in Haleon during the first quarter valued at approximately $27,000. Finally, GW&K Investment Management LLC increased its stake in Haleon by 308.4% in the 1st quarter. GW&K Investment Management LLC now owns 3,529 shares of the company’s stock valued at $29,000 after buying an additional 2,665 shares during the period. Hedge funds and other institutional investors own 6.67% of the company’s stock.
Haleon Stock Down 0.9 %
HLN opened at $8.05 on Thursday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.54 and a current ratio of 0.84. The business has a 50 day moving average price of $8.35 and a 200 day moving average price of $8.39. Haleon plc has a twelve month low of $5.84 and a twelve month high of $9.05.
Haleon Cuts Dividend
The business also recently announced a — dividend, which will be paid on Thursday, October 5th. Investors of record on Friday, August 25th will be paid a dividend of $0.046 per share. This represents a yield of 1.3%. The ex-dividend date is Thursday, August 24th.
Analysts Set New Price Targets
Separately, Investec upgraded Haleon from a “sell” rating to a “hold” rating in a research note on Tuesday, August 8th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $364.00.
View Our Latest Report on Haleon
Haleon Profile
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements.
Featured Stories
- Five stocks we like better than Haleon
- Golden Cross Stocks: Pattern, Examples and Charts
- How You Can Reverse Engineer Michael Burry’s Latest Buy
- How to Choose Top Rated Stocks
- The Odds Are High Costco Will Declare a Special Dividend SoonÂ
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- 3 Mid-Cap Momentum Plays to Ride Into Q4
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.
